Yasmin Sultana Selected Research

lavandulol

5/2011

Role of novel terpenes in transcutaneous permeation of valsartan: effectiveness and mechanism of action.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasmin Sultana Research Topics

Disease

4	Hypertension (High Blood Pressure) 09/2016 - 03/2006
3	Schizophrenia (Dementia Praecox) 01/2019 - 12/2015
3	Erythema 05/2011 - 06/2008
3	Edema (Dropsy) 05/2011 - 06/2008
3	Tuberculosis (Tuberculoses) 02/2009 - 01/2006
3	Bacterial Conjunctivitis 05/2006 - 08/2004
2	Skin Neoplasms (Skin Cancer) 04/2019 - 01/2015
2	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 12/2015
1	Infections 10/2022
1	Onychomycosis (Tinea Unguium) 10/2022
1	Drug-Related Side Effects and Adverse Reactions 04/2022
1	Pain (Aches) 12/2021
1	Stomach Ulcer (Gastric Ulcer) 12/2021
1	Osteoarthritis 12/2021
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 12/2021
1	Inflammation (Inflammations) 12/2021
1	Vascular Diseases (Vascular Disease) 09/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 09/2021
1	Uveitis 04/2021
1	Posterior Uveitis 04/2021
1	Toxic Optic Neuropathy 04/2021
1	Osteoporosis 01/2021
1	Neoplasms (Cancer) 04/2019
1	Brain Neoplasms (Brain Tumor) 10/2018
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2017
1	Central Nervous System Diseases (CNS Diseases) 01/2017
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2016
1	Type 2 Diabetes Mellitus (MODY) 01/2016
1	Epilepsy (Aura) 02/2015
1	Actinic Keratosis 01/2015
1	Glaucoma 02/2014
1	Eye Diseases (Eye Disease) 04/2006

Drug/Important Bio-Agent (IBA)

10	Pharmaceutical PreparationsIBA 04/2022 - 09/2005
4	Terpenes (Terpenoids)IBA 10/2022 - 06/2008
3	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2019 - 12/2015
3	LipidsIBA 10/2018 - 02/2015
3	Ophthalmic Solutions (Eye Drops)IBA 02/2014 - 08/2004
2	safranalIBA 10/2022 - 05/2011
2	Liposomes (Liposome)IBA 01/2021 - 12/2016
2	ChitosanIBA 01/2019 - 02/2014
2	Valsartan (Vals)FDA Link 09/2016 - 05/2016
2	beta-citronelleneIBA 05/2011 - 03/2011
2	PefloxacinIBA 09/2005 - 08/2004
1	Fluconazole (Zonal)FDA LinkGeneric 10/2022
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2021
1	Pentosan Sulfuric Polyester (Pentosan Polysulfate)FDA Link 12/2021
1	Hyaluronic Acid (Hyaluronan)IBA 12/2021
1	Endothelial Growth FactorsIBA 09/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2021
1	Bevacizumab (Avastin)FDA Link 09/2021
1	PolyvinylsIBA 04/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2021
1	Everolimus FDA Link 04/2021
1	CaprolactamIBA 04/2021
1	fisetinIBA 04/2019
1	CytokinesIBA 04/2019
1	Glutathione (Reduced Glutathione)IBA 04/2019
1	CatalaseIBA 04/2019
1	Lipid NanoparticlesIBA 01/2019
1	Ursolic AcidIBA 10/2018
1	Therapeutic UsesIBA 01/2017
1	Glutamic Acid (Glutamate)FDA Link 01/2017
1	Riluzole FDA LinkGeneric 01/2017
1	diacereinIBA 12/2016
1	Pioglitazone (Actos)FDA Link 01/2016
1	vinpocetineIBA 12/2015
1	Lamotrigine (Lamictal)FDA LinkGeneric 02/2015
1	carbopol 940 (sodium polyacrylate)IBA 01/2015
1	Antineoplastic Agents (Antineoplastics)IBA 01/2015
1	carboxypolymethyleneIBA 01/2015
1	Fluorouracil (Carac)FDA LinkGeneric 01/2015
1	dorzolamide (Trusopt)FDA LinkGeneric 02/2014
1	prenolIBA 05/2011
1	Acetates (Acetic Acid Esters)FDA Link 05/2011
1	lavandulolIBA 05/2011
1	rose-oxideIBA 03/2011
1	Losartan (Cozaar)FDA LinkGeneric 04/2010
1	prednisolone acetate FDA LinkGeneric 04/2010
1	Dosage Forms (Dosage Form)IBA 02/2009
1	Rifampin (Rifampicin)FDA LinkGeneric 02/2009
1	Sucrose (Saccharose)IBA 02/2009
1	GelatinIBA 02/2009
1	Pinacidil (Pindac)FDA Link 03/2006
1	Drug CarriersIBA 01/2006
1	Polymethyl Methacrylate (Sol)IBA 08/2004

Therapy/Procedure

4	Therapeutics 10/2022 - 01/2017
1	Microspheres (Microsphere) 02/2009
1	Drug Therapy (Chemotherapy) 01/2006